30

Ningbo Tianyi Medical Appliance Co. Ltd.

301097 · SHE · Healthcare / Medical Instruments & Supplies

34.35CNY+0.40 (+1.18%)

Price History

Full chart

Market Stats

Previous Close33.95
Open33.80
Day Range33.63 – 35.30
52-Week Range29.10 – 47.92
Volume1.33M
Market Cap2.83B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.09
Dividend Yield1.44%
Beta0.39
50-Day Avg33.57
200-Day Avg37.81

About

Ningbo Tianyi Medical Appliance Co., Ltd. engages in the research and development, production, and sale of medical polymer consumables and other medical devices for blood purification and ward nursing fields in China, Hong Kong, Macao, Taiwan, and internationally. The company offers hemodialysis products, including blood tubing system, artis tubing set, hemofiltration tubing, AVF, hemodialysis concentrates, bicarbonate powder, hemodialysis powder, citric acid disinfectant; and CRRT consumables, such as customized tubing, low body weight hemofilters, plasma adsorber, MPS plasma separator, and effluent bag. It also provides single-use oxygen delivery tube, single-use oxygen nasal cannula, single-use oxygen tubing, single-use blood transfusion set, single-use burette-type infusion set with needle, and micro-adjustable infusion set. In addition, the company provides various services comprising technical identification, sterilization, clean workshop, contract technical development, and product research and development, and upgrading services; project management, cost-reduction solution, supply chain management, clinical consultancy and tracking, and sample production and testing services; and product registration support, prototype, and patent service, as well as invention program. The company was incorporated in 1998 and is headquartered in Ningbo, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Zhimin Wu
  • Employees1.51K
  • HeadquartersNo. 788 Mozhi North Road, Ningbo, China, 315121, China
  • Websitehttps://www.tianyi-med.com

Leadership

  • Mr. Zhimin WuChairman of the Board & GM · b. 1963
  • Mr. Kejie ShaoDeputy GM, Financial Director & Accounting Supervisor · b. 1994
  • Mr. Bin WuDeputy GM & Director · b. 1987
  • Mr. Zhongliang ZhangDeputy GM & Employee Director · b. 1976
  • Mr. Meng liang LiDeputy GM & Secretary of the Board · b. 1987
  • Ms. Fang PanDeputy General Manager · b. 1973
  • Mr. Dingan ZhangDeputy General Manager · b. 1974

Financials

Income Statement

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue316.30M378.87M414.73M399.33M380.92M418.96M575.76M
Growth (%)-+19.78%+9.46%-3.71%-4.61%+9.98%+37.43%
Cost of Revenue191.50M215.92M257.03M260.19M238.25M268.62M328.33M
Gross Profit124.81M162.96M157.70M139.14M142.67M150.34M247.43M
Gross Margin39.46%43.01%38.03%34.84%37.46%35.88%42.97%
Operating Expense49.15M46.91M54.76M71.27M109.26M169.75M199.13M
Operating Income75.66M116.05M102.94M67.87M33.42M-19.41M48.30M
Operating Margin23.92%30.63%24.82%17.00%8.77%-4.63%8.39%
EBITDA104.55M139.55M127.72M135.23M117.42M49.73M59.42M
EBITDA Margin33.06%36.83%30.80%33.86%30.83%11.87%10.32%
Net Income63.20M87.15M78.29M85.60M63.57M-743.97K-16.22M
Net Income Margin19.98%23.00%18.88%21.44%16.69%-0.18%-2.82%
R&D16.07M15.97M20.26M28.06M31.10M60.47M56.93M
R&D as % of Total Revenue5.08%4.22%4.89%7.03%8.16%14.43%9.89%
Interest Expense11.50M3.43M7.08M6.79M9.65M9.56M13.18M
Interest Expense % of Total Revenue3.64%0.91%1.71%1.70%2.53%2.28%2.29%

Balance Sheet

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets485.60M672.90M807.28M1.63B1.77B1.79B2.07B
Total Liabilities181.61M281.76M337.85M392.01M487.17M602.46M920.15M
Total Equity304.00M391.15M469.44M1.23B1.27B1.19B1.15B
Cash107.07M185.63M345.66M448.97M192.16M407.23M436.86M
Net Debt----165.00M-90.37M

Cash Flow

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow65.46M121.38M133.03M50.18M72.64M58.85M95.12M
Capital Expenditure58.33M68.08M66.28M149.09M221.16M107.00M305.57M
Free Cash Flow7.13M53.30M66.75M-98.91M-148.52M-48.14M-210.44M
Dividends Paid64.92M3.89M6.92M21.85M39.12M38.76M41.58M
FCF to OCF10.89%43.91%50.17%-197.12%-204.47%-81.80%-221.23%
Dividend Paid to FCF910.27%7.29%10.37%-22.09%-26.34%-80.50%-19.76%

Earnings

Report DateJun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------
EPS Actual0.420.53-0.020.170.460.110.030.070.11-0.10-0.090.060.060.13-0.450.120.11
Surprise-----------------
Timing-----------------

Key Statistics & Ratios

Market Cap2.83B
Enterprise Value3.18B
Trailing P/E0.00
Forward P/E0.00
Price / Sales4.12
Price / Book2.80
EPS-0.09
Book Value12.84
Revenue (TTM)686.70M
Gross Profit (TTM)314.58M
EBITDA127.98M
Profit Margin-1.40%
Operating Margin1.78%
Return on Equity-0.95%
Return on Assets1.82%
Shares Outstanding81.61M
Shares Float22.63M
Beta0.39
Dividend Yield1.44%
Dividend Rate0.50
Payout Ratio227.27%

Dividends

20261×
0.50Jun 2, 2026
20251×
0.36May 16, 2025
20241×
0.36May 28, 2024
20231×
0.36Jul 6, 2023
20221×
0.18Jun 7, 2022

Stock Splits

  • Jun 8, 20261.4004:1